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often shows restricted diffusion around the surgical cavity on the ﬁrst post-operative MRI. When acute
clinical deterioration occurs with the typical MRI ﬁndings, the material must be removed surgically.
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Hemostaticmaterials are used routinely after intracranial surgery.
Oxidized cellulose (SURGICEL, Ethicon 360, Johnson & Johnson, USA)
is the most common but any hemostatic material can rarely cause
post-operative complications both systemically and intracranially by
migration, swelling with compression of adjacent tissues, and
radiologic appearances mimicking hematomas, abscesses or recur-
rent tumor with or without clinical symptoms [1–3]. Most patients
with intracranial lesions mimicking abscess or recurrent tumor
presentmonths to years after craniotomy [3].We report four patients
with acute post-operative symptomatic lesions related to oxidized
cellulose within 16 days of intracranial tumor resection.Case reports
Case one is a 52-year-old woman with a low grade oligoden-
drogliomadiagnosed12years previously and treatedwith four cyclesing was provided for this
emorial Sloan-Kettering
SA. Tel.: +1 212 639 7997;
).
c. Open access under CC BY-NC-NDof procarbazine, CCNU and vincristine 10 years prior, 10 cycles of
temozolomide 3 years previously, and radiotherapy 15 months
before the current craniotomy. She presented with expansion of an
enhancing left frontal lesion which was hypometabolic on PET but
continued to grow. On resection it was a mixture of residual low
grade oligodendroglioma and treatment effect. Immediate post-
operativeMRI showedonly the expectedpost-operative changes. The
patientwas dischargedwithout any neurologic deﬁcit. Five days after
her craniotomy she developed a new right hemiparesis and
expressive aphasia that worsened over three days. CT showed an
increased left frontal cystic lesion andMRI revealed a T1 hypointense
cystic lesionwitha thin rimof peripheral enhancementand increased
edema with areas of restricted diffusion corresponding to the
enhancing rim (Fig. 1). She was treated with dexamethasone and
mannitol followed by hypertonic saline (2%) without beneﬁt. The
patient was taken for surgical exploration where a yellowish
inﬂammatory exudatewithout hemorrhagewas seen. Cultures failed
togrowanyorganismandpathology showedacute inﬂammationand
residual oxidized cellulose material without any identiﬁable micro-
organisms or tumor present (Fig. 1). The cavity was irrigated and the
patient recoveredover the next fourweekswith gradual resolution of
the enhancing lesion onMRI. She is alive and well 3½ years later and
has required no further treatment.
Case two is a 50-year-old man diagnosed with a low grade
glioma 11 months prior that was partially resected and then license.
Fig. 1. Case 1: Magnetic resonance imaging (MRI) T1 pre-contrast (A) shows a hyperintense area immediately after resection. Computed tomography (CT) (B) and MRI
(C) eight days post-operatively showing larger cystic lesion with surrounding area of edema and mass effect with a thin rim of enhancement on T1 after gadolinium (D) and
corresponding areas of restricted diffusion (E,F). MRI FLAIR (G) ﬁve days later after interval removal of inﬂammatory debris, oxidized cellulose and irrigation. Follow up MRI
FLAIR (H) and T1 post-contrast (I) four months later show complete resolution. Empty “ghost ﬁber” proﬁles typical of Surgicel are present in cellular debris (arrows) (J).
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over two weeks and had a new enhancing right frontal lesion
which was resected with the use of oxidized cellulose and FloSeal
as hemostatic agents; pathology revealed glioblastoma. Twelve
hours after surgery he experienced worsening left hemiparesis
that progressed over the next two days without response to
dexamethasone. MRI showed worsening edema around a cystic
lesion with rim enhancement and corresponding restricted
diffusion. On the fourth post-operative day the patient had re-
resection, and the surgical cavity contained a thick exudate, a
small amount of residual oxidized cellulose (1 cm patch) and
GELFOAM® (Pﬁzer, New York, NY, USA) (three 8 mm strips).
Duragen had been used as a dural substitute, and this was
contiguous with the underlying open cavity. Residual foreign
materials were removed and the area was irrigated. DuraGuard
was used to close the dura and the bone plate was cleaned and
secured as per routine craniotomy procedures. Culture of the cyst
content failed to grow any microorganisms and pathological
examination showed only inﬂammatory elements borderingFig. 2. Case 2: Heterogeneous ring-enhancing lesion on MRI (A) prior to resection. Eight
increased in size over the next twenty-four hours with a thin rim of peripheral enhancem
material with inﬂammatory cells seen on the periphery (E).aggregated GELFOAM material (Fig. 2). The patient had immediate
improvement in strength after surgery and continues to do well
six months later after radiation and temozolomide with bevaci-
zumab as part of a clinical trial.
Case three is a 44-year-old woman who underwent resection of
a right frontal glioblastoma with lining of the surgical cavity with a
single layer of oxidized cellulose for hemostasis. She experienced
worsening hemiparesis 16 days later due to an enlarging cystic
lesion with a T1 hyperintense and enhancing rim with restricted
diffusion and surrounding edema. She did not respond to increased
steroids, so surgical exploration was performed which revealed
acute inﬂammation. The patient recovered well and continued
therapy.
Case four is a 65-year-old man who presented with memory
difﬁculties and was found to have a left frontal enhancing lesion
which was resected; pathology revealed glioblastoma. Microﬁbrillar
collagen AVITENE® (Davol, Inc., Warwick, RI, USA) sheets and
FLOSEAL® (Baxter, Fremont, CA, USA) were used to line parts of the
cavity for hemostatic control. In the immediate post-operative periodhours post-operative CT (B) showing cystic lesion with small amount of air which
ent on MRI (C) and rim of restricted diffusion (D). Gelfoam is evident in the resected
Fig. 3. Case 4: (A) Pre-operative post-gadolinium T1 MRI showing the left frontal
glioblastoma. (B) 48 hour post-operative T1 contrast enhanced and diffusion
(C) MRI demonstrating extensive resection. (D) MRI 11 days after initial resection
showing prominent enhancement on post-gadolinium images, little surrounding
edema on FLAIR sequence (E) and stable diffusion changes (F). (G) Histology of
resected material demonstrating inﬂammation and a histocytic reaction to the
foreign material (arrows).
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over several days.However, hehad frequentepisodes of speecharrest
despite adjustment of his anti-epileptics; EEG showed occasional
epileptiform spikes in the left parieto-central region. MRI done twodays post-operatively revealed expected changes with the resection
cavity containing ﬂuid, blood and air with rim enhancement and
restricted diffusion (Fig. 3). Despite treatment for seizures, hyper-
tonic saline, mannitol, and high doses of dexamethasone, the patient
did not improve. Repeat MRI was unchanged (Fig. 3). The patient
returned to the operating room 15 days after the initial resection and
surgical exploration showed a thick exudate, degrading hemostatic
materials and ﬂuid with blood products, but no blood clot. This was
removed and the cavity thoroughly irrigated. On pathology, cellular
debris, blood and hemostatic material were identiﬁed but no tumor.
Thepatienthad an immediate improvement in language functionand
no further episodes of aphasia. He was tapered down to a single
antiepileptic drug and has been doing well for the past four months.Discussion
Our patients all showed rapidly enlarging cystic lesions hours to
16 days after tumor resection, inconsistent with residual tumor and
atypical for infection. Symptomswere delayed by 5–16 days in two of
the patients but the other two had symptoms within hours of
resection, suggesting this reaction can occur rapidly. Acute inﬂam-
mation was found on pathologic examination after re-resection, but
stains and cultures were all negative. No patient had fever or an
elevated peripheral white count post-operatively although a pre-
dominance of polymorphonuclear white cells (~90%) was typical. All
of our patients had clinical worsening with seizures or lateralizing
signs and none responded to high dose dexamethasone. None had a
history of allergies or prior exposure to hemostatic materials that we
could identify. All required removal of the inciting material and
experienced rapid clinical improvement.
On CT, oxidized cellulose can mimic hematoma or abscess with
irregular, mixed attenuation lesions, some containing air with
surrounding edema. In the brain, a thin rim of enhancement can be
seen on MRI and has been reported for CT as well. Marked edema is
characteristic and progressive enlargement of the cystic component
was also seen. We also observed areas of restricted diffusion
corresponding to the rim of enhancement in all of our cases.
Unfortunately, most patients did not have sequences most sensitive
to blood products.
Though largely considered benign and bioabsorbable, in vitro
studies have shown that oxidized cellulose is cytotoxic even at
diluted doses [4]. Different hemostatic bioabsorbable materials can
be retained for long periods after surgery and can provoke
inﬂammation and granuloma formation [5]. Macrophages are
required for clearance and different individuals have a varying
propensity for clearing the material versus granuloma formation.
In conclusion, clinicians caring for patients with brain tumors
need to be aware of the uncommon occurrence of retained
hemostatic material provoking acute inﬂammatory responses
mimicking abscess and recurrent tumor, as immediate improve-
ment occurs with, and requires, removal of the agent.References
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